
Nieuwlandlaan 9 (B-150)
B-3200 Aarschot
Company
profile
The company markets it’s product only
outside the European Union and has adopted a stringent focus on the quality of
its product (a lot of the competing products are made in
Arenco’s
products were the first
artemisinine-based drugs that got registered in
The range of
products currently includes tablets (ACT's) and ampoules for intra-muscular injection
(adult and paediatric form). Arenco is working together with some leading
research institutions to continue to develop new and innovative products, all
of them targeted at malaria and based on artemisinine-derivatives.
Arenco is a
profitable privately owned company, jointly owned by a medical doctor and an
early-stage investor.
To contact us for more information click here
Tel : +32 16 56 56 06
Fax + 32 16 56 56 03
e-mail : Arenco@arenco.be